整合制药资源以应对医疗服务不足人群的疾病。
Assembling Pharma Resources to Tackle Diseases of Underserved Populations.
作者信息
Kempf Dale J, Marsh Kennan C
机构信息
Discovery and Development Sciences, AbbVie, 1 North Waukegan Road, North Chicago, Illinois 60064, United States.
出版信息
ACS Med Chem Lett. 2020 Mar 27;11(6):1094-1100. doi: 10.1021/acsmedchemlett.0c00051. eCollection 2020 Jun 11.
Abstract
Tropical diseases that disproportionally affect the world's poorest people have traditionally been neglected from research efforts toward the discovery and development of new and effective therapies. Over the past two decades, major global health funders have made efforts to bring together various research institutions to work together in these disease areas offering little or no commercial return. This work describes the genesis and growth of an informal program devoted to contributing to new therapies for neglected tropical diseases within the environment of a major biopharmaceutical company (AbbVie).
摘要
传统上，那些对世界上最贫困人口影响尤为严重的热带疾病，在旨在发现和开发新的有效疗法的研究工作中一直被忽视。在过去二十年里，全球主要的卫生资助机构努力促使各类研究机构在这些几乎没有或完全没有商业回报的疾病领域开展合作。本文介绍了一个非正式项目的起源与发展，该项目致力于在一家大型生物制药公司（艾伯维）的环境中，为被忽视热带疾病的新疗法做出贡献。
相似文献
1
Assembling Pharma Resources to Tackle Diseases of Underserved Populations.整合制药资源以应对医疗服务不足人群的疾病。
ACS Med Chem Lett. 2020 Mar 27;11(6):1094-1100. doi: 10.1021/acsmedchemlett.0c00051. eCollection 2020 Jun 11.
3
The burden of disease among the global poor.全球贫困人口的疾病负担。
Lancet. 1999 Aug 14;354(9178):586-9. doi: 10.1016/S0140-6736(99)02108-X.
4
Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases.扩大“大胆目标”：消除世界高流行的被忽视热带病。
Vaccine. 2011 Dec 30;29 Suppl 4:D104-10. doi: 10.1016/j.vaccine.2011.06.024. Epub 2011 Dec 19.
5
The Role of Nurses and Community Health Workers in Confronting Neglected Tropical Diseases in Sub-Saharan Africa: A Systematic Review.护士和社区卫生工作者在应对撒哈拉以南非洲被忽视热带病中的作用：一项系统评价
PLoS Negl Trop Dis. 2016 Sep 15;10(9):e0004914. doi: 10.1371/journal.pntd.0004914. eCollection 2016 Sep.
6
A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.少数几种被忽视疾病的“扶贫”疫苗已经存在，但世界上最贫穷的 10 亿人需要更多的疫苗。
Health Aff (Millwood). 2011 Jun;30(6):1080-7. doi: 10.1377/hlthaff.2011.0317.
7
Advances in the discovery and development of trematocidal drugs.在抗吸虫药物的发现和开发方面的进展。
Expert Opin Drug Discov. 2007 Oct;2(s1):S9-S23. doi: 10.1517/17460441.2.S1.S9.
8
Why Funding for Neglected Tropical Diseases Should Be a Global Priority.为什么资助被忽视的热带病应该成为全球优先事项
Clin Infect Dis. 2018 Jul 18;67(3):323-326. doi: 10.1093/cid/ciy349.
9
More medicines alone cannot ensure the treatment of neglected tropical diseases.仅靠更多的药物并不能确保被忽视热带病的治疗。
Lancet Infect Dis. 2019 Sep;19(9):e330-e336. doi: 10.1016/S1473-3099(19)30160-4. Epub 2019 May 31.
10
New Vaccines for the World's Poorest People.为世界最贫困人口研发新疫苗。
Annu Rev Med. 2016;67:405-17. doi: 10.1146/annurev-med-051214-024241. Epub 2015 Sep 3.
引用本文的文献
1
Onchocerciasis drug development: from preclinical models to humans.盘尾丝虫病药物研发：从临床前模型到人体。
Parasitol Res. 2021 Dec;120(12):3939-3964. doi: 10.1007/s00436-021-07307-4. Epub 2021 Oct 13.
本文引用的文献
1
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned. bumped 激酶抑制剂作为治疗顶复门寄生虫病的药物：经验教训。
Int J Parasitol. 2020 May;50(5):413-422. doi: 10.1016/j.ijpara.2020.01.006. Epub 2020 Mar 26.
2
In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae.在感染利什曼原虫的西格氏硕大利什曼原虫成虫和微丝蚴中，用 ABBV-4083 耗竭沃尔巴克氏体的体内动力学研究。
PLoS Negl Trop Dis. 2019 Aug 5;13(8):e0007636. doi: 10.1371/journal.pntd.0007636. eCollection 2019 Aug.
3
Preclinical development of an oral anti- macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.抗大环内酯类药物的临床前开发用于治疗淋巴丝虫病和盘尾丝虫病。
Sci Transl Med. 2019 Mar 13;11(483). doi: 10.1126/scitranslmed.aau2086.
4
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.发现 ABBV-4083，一种泰乐菌素 A 的新型类似物，具有强大的抗沃尔巴克氏体和抗丝虫活性。
PLoS Negl Trop Dis. 2019 Feb 28;13(2):e0007159. doi: 10.1371/journal.pntd.0007159. eCollection 2019 Feb.
5
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.UCT943，一种用于治疗疟疾的新一代恶性疟原虫 PI4K 抑制剂的临床前候选药物。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00012-18. Print 2018 Sep.
6
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.单剂量 DSM265 治疗无并发症恶性疟原虫或间日疟原虫感染患者的抗疟活性：一项概念验证、开放标签、2a 期研究
Lancet Infect Dis. 2018 Aug;18(8):874-883. doi: 10.1016/S1473-3099(18)30309-8. Epub 2018 Jun 13.
7
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis. bumped 激酶抑制剂 1369 在猪隐孢子虫急性腹泻模型中的治疗效果。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00147-18. Print 2018 Jul.
8
2 SCI/RSC Symposium on Medicinal Chemistry for Global Health: A Unique Opportunity for the Field.第二届全球健康药物化学研讨会：该领域的独特机遇。
ACS Infect Dis. 2018 Apr 13;4(4):424-428. doi: 10.1021/acsinfecdis.8b00022.
9
Oral fexinidazole for human African trypanosomiasis.口服非昔硝唑治疗人类非洲锥虫病。
Lancet. 2018 Jan 13;391(10116):100-102. doi: 10.1016/S0140-6736(18)30019-9.
10
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.一项评估 DSM265 对经蚊叮和直接静脉接种控制的人体疟原虫感染前期红内期疟原虫感染的预防活性的随机试验。
J Infect Dis. 2018 Feb 14;217(5):693-702. doi: 10.1093/infdis/jix613.
Zotero 插件